Inspire Your Thinking
Innovation Lab events are exclusive conferences for marketers of drugs in the rare disease space to learn and share best practices in developing relationships and communication strategies across the brand lifecycle.
In the rare disease space there are few competing brands, which creates a unique opportunity to share best practices. We all face the same challenges—how to determine optimum price, how to assess market size, how to best engage the patient community—and there is great benefit to sharing our collective experiences and knowledge. This is the idea behind our industry-only Innovation Lab events.
More than passive "sit and listen" sessions, these workshops are engaging, interactive events from which attendees emerge smarter and armed with real marketing solutions for their company or brand(s).
Innovation Lab events are by invitation only. If you're interested in attending our next Innovation Lab event, please register now!
A common misperception among healthcare marketers is that people with rare diseases and their caregivers will always be compliant with medicine treatment. But the reality is nonadherence rates are especially high among patients who require lifelong medications.
This white paper outlines the key factors of nonadherence, shows how the challenges are multidimensional, and debunks the myth that adherence is a “patient problem.” You can also learn more on how to build an effective adherence program, why mapping the patient experience is vital, and the benefit of developing programs using evidence-based approaches.
To Unlock your brand's potential, build a better adherence program, and help improve outcomes for all stakeholders.
Spring 2014 » The Great Orphan Drug Debate '14
What better place to turn up the heat on some of the hottest healthcare topics than at Bobby Van's Steakhouse in Washington, DC, following day 1 of the World Orphan Drug Congress (WODC)? This year's Great Orphan Drug Debate gave industry leaders an exclusive, closed-door forum in which to discuss and defend 2 sizzling topics regarding the future of patients, providers, and pricing models.
Marketers of orphan drugs and rare disease therapies convened at the 7th Annual Innovation Lab in Boston, MA. The event provided a forum for participants to discern, discuss, and debate key issues in the industry, including patient community engagement, communication strategies across the brand lifecycle, value propositions and pricing models, and patient insights perspectives.
Spring 2013 » The Great Orphan Drug Debate: Washington, DC
At Charlie Palmer Steak Restaurant in Washington, DC, when the cherry blossoms were in bloom, key stakeholders of orphan drugs for rare and ultra-rare diseases gathered for the Great Orphan Drug Debate of 2013, sponsored by Compass Healthcare Marketers and Medical Marketing Economics, LLC (MME). The Great Debate is an annual event that provides the opportunity for industry leaders to hear opposing views on pressing issues and engage in a lively discussion. This year's debates focused on value propositions.
© 2014 Compass Healthcare Marketers®. All rights reserved.